Replies to post #118203 on Biotech Values

[esimae]

Aren't you forgetting about Sandoz massive overstock in all this. Sure as long as the overstock is being burned off they can handle a lot of extra end user sales. But since they have swallowed T's koolaid I doubt Novartis has made the considerable investment to handle more than 45% of the market.